Advanced search
Publication Cover
Journal of Toxicology: Clinical Toxicology Volume 25, 1987 - Issue 3
Journal homepage
25
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Repeated Oral Doses of Activated Charcoal and the Clearance of Tobramycin, a Non-Absorbable Drug

William A. Watson Departments of Pharmacy and Pharmaceutics, School of Pharmacy State University of New York at Buffalo The Clinical Pharmacokinetics Laboratory, Buffalo, New York, 14209; Department of Anesthesiology, Millard Fillmore Hospital, 3 Gates Circle, Buffalo, New York, 14209
,
Tammy C. Jenkins Departments of Pharmacy and Pharmaceutics, School of Pharmacy State University of New York at Buffalo The Clinical Pharmacokinetics Laboratory, Buffalo, New York, 14209; Department of Anesthesiology, Millard Fillmore Hospital, 3 Gates Circle, Buffalo, New York, 14209
,
Norma Velasquez Departments of Pharmacy and Pharmaceutics, School of Pharmacy State University of New York at Buffalo The Clinical Pharmacokinetics Laboratory, Buffalo, New York, 14209; Department of Anesthesiology, Millard Fillmore Hospital, 3 Gates Circle, Buffalo, New York, 14209
&
Jerome J. Schentag Departments of Pharmacy and Pharmaceutics, School of Pharmacy State University of New York at Buffalo The Clinical Pharmacokinetics Laboratory, Buffalo, New York, 14209; Department of Anesthesiology, Millard Fillmore Hospital, 3 Gates Circle, Buffalo, New York, 14209
Pages 171-184 | Published online: 25 Sep 2008

References

  • Neuvonen P. J. Clinical pharmacokinetics of oral activated charcoal in acute intoxicants. Clin. Pharmacokinet. 1982; 7: 465–489
  • Holt L. E., Holtz P. H. The black bottle. J. Ped. 1963; 63: 306–314
  • Park G. D., Spector R., Goldberg M. J., Johnson G. F. Expanded role of charcoal therapy in the poisoned and overdosed patient. Arch. Intern. Med. 1986; 146: 969–973
  • Neuvonen P. J., Olkkola K. T. Effect of dose of charcoal on the absorption of disopyramide, indomethacin and trimethoprim by man. Eur. J. Clin. Pharmacol. 1984; 26: 761–767
  • Galinsky R. E., Levy G. Evaluation of activated charcoal‐sodium sulfate combination for inhibition of acetaminophen absorption and repletion of inorganic sulfate. Clin. Toxicol. 1984; 22: 21–30
  • Levy G., Tsuchiya T. Effect of activated charcoal on aspirin absorption in man. Clin. Pharmacol. Ther. 1972; 13: 317–322
  • Neuvonen P. J., Elfving S. M., Elonen E. Reduction of absorption of digoxin, phenytoin, and aspirin by activated charcoal in man. Eur. J. Clin. Pharmacol. 1978; 13: 213–218
  • Guay D. R.P., Meatherall R. C., Macaulay P. A., Yeung C. Activated charcoal adsorption of diphenhydramine. Int. J. Clin. Pharmacol. Ther. Toxicol. 1984; 22: 395–400
  • Neuvonen P. J., Elonen E. Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man. Eur. J. Clin. Pharmacol. 1980; 17: 51–57
  • Honcharik N., Anthone S. Activated charcoal in acute cyclosporin overdose. Lancet 1985; 1: 1051
  • Pond S., Jacobs M., Marks J., Garner J., Goldschlager N., Hansen D. Treatment of digitoxin overdose with oral activated charcoal. Lancet 1981; 2: 1177–8
  • Neuvonen P. J., Elonen E., Mattila M. J. Oral activated charcoal and dapsone elimination. Clin. Pharmacol. Ther. 1980; 27: 823–827
  • Karkkainen S., Neuvonen P. J. Effect of oral charcoal and urine pH on sotalol pharmacokinetics. Int. J. Clin. Pharmacol. Ther. Toxicol. 1984; 22: 441–446
  • Lalonde R. L., Desphande R., Hamilton P. P., McLean W. M., Greenway D. C. Acceleration of digoxin clearance by activated charcoal. Clin. Pharmacol. Ther. 1985; 37: 367–371
  • Gadgil S. D., Damle S. R., Advani S. H., Vaidya A. B. Effect of activated charcoal on the pharmacokinetics of high‐dose methotrexate. Cancer Treat. Rep. 1982; 66: 1169–1171
  • Berg M. J., Berlinger W. G., Goldberg M. J., Spector R., Johnson G. F. Acceleration of the body clearance of phenobarbital by oral activated charcoal. N. Engl.J. Med. 1982; 307: 642–644
  • Radomski L., Park G. D., Goldberg M. J., Spector R., Johnson G. F., Quee C. K. Model for theophylline overdose treatment with oral activated charcoal. Clin. Pharmacol. Ther. 1984; 35: 402–408
  • Berlinger W. G., Spector R., Goldberg M. J., Johnson G. F., Quee C. K., Berg M. J. Enhancement of theophylline clearance by oral activated charcoal. Clin. Pharmacol. Ther. 1983; 33: 351–354
  • Levy G. Gastrointestinal clearance of drugs with activated charcoal. N. Engl. J. Med. 1982; 307: 676–678
  • Park G. D., Spector R., Goldberg M. J., Johnson G. F. Expanded role of charcoal therapy in the poisoned and overdosed patient. Arch. Intern. Med. 1986; 146: 969–973
  • Sande M. A., Mandell G. L. The Aminoglycosides. The Therapeutic Basis of Pharmacology, L. Gilman, S. Goodman, A. Gilman. MacMillan Press, New York 1980; 1162–1180
  • Schentag J. J. Aminoglycosides. Applied Pharmaco‐kinetics, W. Evans, J. J. Schentag, W. Jusko. Applied Therapeutics Inc., Washington 1980; 174–209
  • Konomi K., Yamamoto H., Egashira K., Kawauchi Y., Furusawa T., Hisatsugu T. Basic and clinical studies of tobramycin in the field of biliary tract infections and other surgical infections. Chem. 1975; 23: 1233–1239
  • Schentag J. J. Gentamicin tissue pharmacokinetics. Applications of Pharmacokinetics to Patient Care, C. A. Walker, L. P. Tterelikkis. Praeger Publishers, New York 1982; 135–146
  • Barnhill B. M., Lyon J. A. MicroNONLINc.r Programs in PharmacokineticsFirst edition, E. Swarbrick. Dekker Inc., New York 1972
  • Pond S. M. Role of repeated oral doses of activated charcoal in clinical toxicology. Med. Toxicol. 1986; 1: 3–11
  • Adelman M., Evans E., Schentag J. J. Two‐compartment comparison of gentamicin and tobramycin in normal volunteers. Antimicrob. Agents Chemo. 1982; 22: 800–804
  • Schentag J. J., Cumbo T. J., Jusko W. J., Plaut M. E. Gentamicin tissue accumulation and nephrotoxic reactions. J. Am. Med. Assoc. 1978; 240: 2067–2069

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.